Current Neuro-Oncology

Volume 27 Number 15
31 May 2025

Home > Publications > Current Neuro-Oncology > Volume 27, Year 2025 > Number 15, 31 May

Dasgupta A, Mani S, Chatterjee A, Kannan S, Moiyadi A, Shetty P, Singh V, Menon N, Sahu A, Choudhary A, Bhattacharya K, Puranik A, Dev I, Epari S, Sahay A, Shah A, Bano N, Shaikh F, Gupta T.
Study protocol of short versus long-term levetiracetam in brain tumors (LIBRA): a phase 3 randomized controlled trial.
BMC Cancer. 2025 May 21;25(1):911. doi: 10.1186/s12885-025-14305-7. PMID: 40399827. Interventional study protocol. ˍ

Qiu X, Liang L, Chen L, Hong P, Lin W, Liu J, Zhou Z, Zhu W, Wu T, Pan M, Zhong Y, Gao J, Qin Z, Wang Y.
An Analysis for IDH-Mutant Grade 4 Astrocytoma Based on WHO CNS 5: Implication of Clinical Practice.
Ann Clin Transl Neurol. 2025 May 21. doi: 10.1002/acn3.70081. PMID: 40400212. Observational study. ˍ

Bell JB, Sheriff S, Goryawala MZ, Cullison K, Azzam GA, Meshman J, Abramowitz MC, Ivan ME, de la Fuente MI, Mellon EA.
Defining occult disease in glioblastoma using spectroscopic MRI: implications for clinical target volume delineation.
Radiat Oncol. 2025 May 22;20(1):86. doi: 10.1186/s13014-025-02666-z. PMID: 40405247. Observational study. ˍ

Nejo T, Krishna S, Yamamichi A, Lakshmanachetty S, Jimenez C, Lee KY, Baker DL, Young JS, Chen T, Phyu SSS, Phung L, Gallus M, Maldonado GC, Okada K, Ogino H, Watchmaker PB, Diebold D, Choudhury A, Daniel AGS, Cadwell CR, Raleigh DR, Hervey-Jumper SL, Okada H.
Glioma-neuronal circuit remodeling induces regional immunosuppression.
Nat Commun. 2025 May 22;16(1):4770. doi: 10.1038/s41467-025-60074-z. PMID: 40404658. Laboratory investigation. ˍ

*Takido Y, Ohka F, Deguchi S, Motomura K, Mitsuya K, Aoki K, Shiba Y, Takeuchi K, Nagata Y, Yamaguchi J, Kibe Y, Fuse Y, Maeda S, Shimizu H, Saito R.
Distant parenchymal recurrence during long-term use of TTFields treatment for glioblastoma.
Int J Clin Oncol. 2025 May 22. doi: 10.1007/s10147-025-02775-5. PMID: 40404987. Observational study. ˍ

Yaşar B, Tanrıkulu B, Danyeli AE, Özek MM.
Aggressive behavior in a molecularly benign tumor: The diagnostic odyssey of a pediatric pilocytic astrocytoma with initial high-grade histologic features and rapid recurrence.
J Neuropathol Exp Neurol. 2025 May 22:nlaf055. doi: 10.1093/jnen/nlaf055. PMID: 40402833. Case report˰ ˍ

Bhargava V.
Lessons Learnt From Glioblastoma Surviving 20 Years Progression Free: A Case Report.
Neurol India. 2025 May 23;73(3):541-543. doi: 10.4103/neurol-india.Neurol-India-D-24-00487. PMID: 40408581. Case report. ˍ

*van Dijck JTJM, Ardon H, Balvers RK, Bos EM, Bosscher L, Brouwers HB, Ho VKY, Hovinga K, Kwee L, Ter Laan M, Nabuurs RJA, Robe PAJT, van Geest S, van der Veer O, Verburg N, Wagemakers M, de Witt Hamer PC, Rodriguez Girondo M, Nandoe Tewarie RDS; Quality Registry Neuro Surgery glioblastoma working group from the Dutch Society of Neurosurgery.
Survival prediction in glioblastoma: 10-year follow-up from the Dutch Neurosurgery Quality Registry.
J Neurooncol. 2025 May 23. doi: 10.1007/s11060-025-05080-3. PMID: 40410639. Observational study. ˍ

Var V, Leu SM, Rommers N, Psychogios MN, Cordier D, Todea RA.
Differentiation of tumor progression from pseudoprogression in glioblastoma patients with GRASP DCE-MRI and DSC-MRI.
J Neuroradiol. 2025 May 24;52(4):101354. doi: 10.1016/j.neurad.2025.101354. PMID: 40419180. Observational study. ˍ

*Gavrjushin AV, Papusha LI, Veselkov AA, Zaitseva MA, Khukhlaeva EA, Konovalov AN, Druy AE.
Liquid biopsy for the detection of H3K27m in patients with brainstem tumors.
Neurosurg Rev. 2025 May 26;48(1):442. doi: 10.1007/s10143-025-03593-z. PMID: 40415124. Observational study˰ ˍ

Pruis IJ, van Dis V, Maas SLN, Balvers RK, van den Bosch TPP, Segbers M, Veldhuijzen van Zanten SEM.
PSMA radioligand uptake correlates with PSMA expression in high-grade glioma and brain metastasis: insights from a prospective PET-MRI guided multiregional biopsy study.
Eur J Nucl Med Mol Imaging. 2025 May 26. doi: 10.1007/s00259-025-07338-4. PMID: 40414994. Interventional study. ˍ

Bertolini G, Trombini T, Zenesini C, Mazza S, Dascola I, Pavarani A, Michiara M, Ceccon G, Peluso A, Calamo Specchia FM, Crafa P, Menozzi R, Giombelli E.
Prognostic impact of second surgical resection in IDH wildtype recurrent glioblastoma following chemo-radiation therapy: a propensity score analysis cohort study.
J Neurooncol. 2025 May 27. doi: 10.1007/s11060-025-05096-9. PMID: 40423938. Observational study˰ ˍ

Deng HZ, Liu XL, Fan WJ, Hua X, Yilihamu Y, Xu Y, Zhang HW, Liu XL, Lin F.
Evaluating Amide Proton Transfer Imaging for Improved Glioma Assessment: Implications for RANO 2.0 Criteria.
Br J Radiol. 2025 May 27:tqaf115. doi: 10.1093/bjr/tqaf115. PMID: 40424341. Observational study˰ ˍ

**Gu J, Li J, Xu Y, Zhang G, Xie J, Jia R, Chen W, Lu Z, Chang C, Wen H, Chang LJ, Ma H, Cai Q.
Preliminary exploration of PSMA CAR-T combined with GD2 CAR-T for the treatment of refractory/relapsed gliomas.
J Transl Med. 2025 May 27;23(1):591. doi: 10.1186/s12967-025-06523-1. PMID: 40420236. Interventional study. ˍ

Mahdizadeh H, Izadpanah A, Nouri Y, Shams P, Daneshjou D, Ahari AA, Tabibkhooei A, Haghighatkhah H, Vosough M, Faranoush P, Azimi M, Yousefi S, Barzegari A, Khosravani A, Asl NS, Faranoush M, Ebrahimi M.
The safety and feasibility of multiple intrathecal injections of allogenic NK cells in pediatrics with refractory/recurrent brain tumors.
BMC Cancer. 2025 May 27;25(1):952. doi: 10.1186/s12885-025-14314-6. PMID: 40426086. Interventional study. ˍ

Lasica AB, Lan Z, Miller JJ, Jiao A, Pan I, Aker L, Prabhakar P, Japo J, Russ A, Westergaard C, Aquilanti E, Chukwueke U, Gonzalez Castro LN, McFaline Figueroa JR, Lee EQ, Nayak L, Beroukhim R, Batchelor TT, Cahill DP, Nakhate V, Lanman T, Pablo Ospina J, Stec N, Patel RV, Meredith DM, Bi WL, Reardon DA, Ligon KL, Huang RY, Wen PY, Youssef G.
Clinical, molecular and radiological predictors of prognosis in newly diagnosed astrocytoma, IDH-mutant, WHO grade 4.
Neuro Oncol. 2025 May 29:noaf133. doi: 10.1093/neuonc/noaf133. PMID: 40440464. Observational study˰ ˍ

Pan S, Chen Y, Zhao S, Pan J, Xu S.
MRI features and prognostic evaluation in patients with subventricular zone-contacting IDH-wild-type glioblastoma.
Radiol Oncol. 2025 May 30;59(2):1-8. doi: 10.2478/raon-2025-0029. PMID: 40459512. Observational study. ˍ

Sanvito F, Kim A, Raymond C, Teraishi A, Everson RG, Nghiemphu PL, Lai A, Chong RA, Nathanson DA, Salamon N, Cloughesy TF, Yao J, Ellingson BM.
Impact of corticosteroid administration on contrast-enhancing volume and diffusion MRI in treatment naïve glioblastoma.
Neuro Oncol. 2025 May 30:noaf136. doi: 10.1093/neuonc/noaf136. PMID: 40443040. Observational study˰ ˍ